February 2023

World-first trial to investigate new medication for 'ice' use

In a world-first, Australian researchers are trialling a new medication to help people who want to stop using crystal methamphetamine, or ‘ice’.

Read more
February 2023

U.S. National Institute funding for NDRI alcohol study

NDRI researchers will lead a project examining the impact physical availability of alcohol has on sales and related harm as part of a $2m grant with colleagues from the United States.

February 2023

NCETA AOD Workforce Reference Group – Call for EoIs

NCETA is seeking specialist and generalist members of the alcohol and other drug (AOD) workforce to join its new AOD Workforce Reference Group.

February 2023

PhD Enterprise Scholarship: High risk drinking among men, potential intervention periods and health promotion strategies to prevent the occurrence of, or change, risky drinking practices.

NCETA are thrilled to announce that, in partnership with the Alcohol and Drug Foundation, we are offering a PhD Enterprise Scholarship to undertake research investigating high risk drinking among m

February 2023

Birdiya Miya homelessness research project exhibition

The Birdiya Miya Homelessness Research Project recently presented an exhibition of art, photography and film created by research participants

February 2023

Interactive online tool reveals latest alcohol harm trends

Version 2.1 of the alcohol harm visualisation tool shows latest alcohol harm trends in Australia.

February 2023

Dr Natasa Gisev awarded funding for world-first study to examine ‘deaths of despair’

NDARC’s Dr Natasa Gisev has been awarded $1,027,327 over four years through the NHMRC Ideas Grant scheme.

February 2023

Professor Jacqueline Bowden on Radio Italiana 531 - Vogliamoci Bene (Love oneself)

NCETA Director, Jacquie Bowden was thrilled to be featured in the popular Radio 531 podcast, Vogliamoci Bene with Mario Corena.

February 2023

New study finds safe and feasible treatment option for methamphetamine withdrawal

A new NCCRED study has found lisdexamfetamine is safe and feasible for treating acute methamphetamine withdrawal.

February 2023

New Video Abstract by NCCRED (VAN): The OLAM Study

The VAN series are bitesize videos showcasing NCCRED supported research produced for consumers and professionals.

February 2023

NCETA Welcomes Student Researcher Drishti Gupta to the team

NCETA are excited to welcome 4th year Medical Student, Drishti Gupta to the team as a visiting student researcher.

Pages